Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $6.32 and traded as low as $4.45. Ampliphi Biosciences shares last traded at $4.78, with a volume of 64,089 shares changing hands.
Ampliphi Biosciences Price Performance
The business has a 50-day simple moving average of $6.32 and a two-hundred day simple moving average of $8.19.
About Ampliphi Biosciences
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
Further Reading
- Five stocks we like better than Ampliphi Biosciences
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
